1. Name Of The Medicinal Product
Cystitis Relief
Cystofem
Canesten Oasis
Paramed Cystitis Relief Sachets
Cysto S
2. Qualitative And Quantitative Composition
Sodium Citrate Dihydrate BP 4.0g
3. Pharmaceutical Form
Granules to be reconstituted for oral administration.
4. Clinical Particulars
4.1 Therapeutic Indications
For the relief of the symptoms of cystitis in women.
4.2 Posology And Method Of Administration
Adult women:
The contents of one sachet dissolved in a glass of water, to be taken three times a day for two days.
Men and children:
Not recommended.
4.3 Contraindications
Patients with diabetes, heart disease, hypertension, history of renal disease or those on a low salt diet.
During pregnancy and lactation.
4.4 Special Warnings And Precautions For Use
If symptoms persist after the two day course of treatment is completed, medical attention should be sought.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
None stated.
4.6 Pregnancy And Lactation
Contraindicated during pregnancy and lactation.
4.7 Effects On Ability To Drive And Use Machines
None stated.
4.8 Undesirable Effects
None stated.
4.9 Overdose
In the unlikely event of overdosage occurring with this product, treatment should be symptomatic.
5. Pharmacological Properties
5.1 Pharmacodynamic Properties
The effect of sodium citrate is to render the urine less acidic.
5.2 Pharmacokinetic Properties
None relevant.
5.3 Preclinical Safety Data
None stated.
6. Pharmaceutical Particulars
6.1 List Of Excipients
Sucrose BP (1.5 g)
Colloidal Silicon Dioxide BP
Saccharin Sodium BP
Cranberry Flavouring
6.2 Incompatibilities
None stated.
6.3 Shelf Life
The granules have a three year shelf life.
The reconstituted solution should be used immediately.
6.4 Special Precautions For Storage
Store below 25°C, in dry place.
6.5 Nature And Contents Of Container
Foil laminate sachets
or
paper (outer surface layer) /polyethylene (outer layer) /aluminium foil (outer layer) /ionomer resin (inner layer) sachets
Each sachet contains 5.575 g of granule enclosed in a cardboard outer.
6.6 Special Precautions For Disposal And Other Handling
None stated.
7. Marketing Authorisation Holder
Wrafton Laboratories Limited
Wrafton
Braunton
North Devon
EX33 2DL
United Kingdom
8. Marketing Authorisation Number(S)
PL 12063/0045.
9. Date Of First Authorisation/Renewal Of The Authorisation
4 December 2003.
10. Date Of Revision Of The Text
26 October 2009.
No comments:
Post a Comment